• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    35.61 Up 0.71(2.03%) May 27, 4:00PM EDT
    Prev Close:34.90
    Open:34.90
    Bid:34.51 x 400
    Ask:35.66 x 700
    1y Target Est:45.70
    Beta:3.47619
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:34.36 - 35.62
    52wk Range:16.64 - 51.99
    Volume:1,524,768
    Avg Vol (3m):3,318,220
    Market Cap:4.03B
    P/E (ttm):N/A
    EPS (ttm):-1.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ACADUp 2.03%4.03B
    AZNDown 0.23%75.60B
    PFEUp 0.52%209.90B
    LLYDown 0.70%79.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):64,744.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.70
    Quarterly EPS Est (Jun-16) :-0.49
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-0.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback